Could the small red bumps on my child's chin be an allergic reaction to neomycin (antibiotic) polymyxin B (antibiotic) fluocinolone (corticosteroid) ear drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Allergic Contact Dermatitis from Neomycin/Polymyxin B/Fluocinolone Ear Drops

Yes, the small red bumps on your child's chin are very likely an allergic reaction to the neomycin/polymyxin B/fluocinolone ear drops. This represents a contact dermatitis reaction that can occur when medication drips onto the skin and causes sensitization.

Understanding the Reaction

Neomycin is particularly known for causing contact sensitivity reactions:

  • The FDA drug label explicitly warns that neomycin sulfate may cause cutaneous sensitization 1
  • Contact sensitivity to neomycin has a high prevalence of 13-30% in patients with chronic otitis externa 2
  • Manifestations typically include low-grade reddening with swelling, dry scaling, and itching 1
  • The reaction can appear simply as small red bumps or failure to heal 1

Why This Happens

The reaction occurs through several mechanisms:

  • Initial sensitization phase occurs over 10-14 days of exposure 2
  • Subsequent exposure leads to delayed-type hypersensitivity reactions 2
  • The reaction can extend beyond the ear canal to involve skin around the ear and neck wherever contact is made 2
  • In your child's case, the medication likely dripped onto the chin during administration

Components That May Cause Reactions

Your child's ear drops contain multiple potential allergens:

  • Neomycin is most commonly associated with contact sensitivity 2
  • Polymyxin B can also cause allergic reactions in 2.3% of patients 3
  • The combination of these antibiotics increases risk of reaction
  • Preservatives and vehicles in the drops may also contribute to sensitivity 2

Management Recommendations

  1. Discontinue the current ear drops immediately

    • The FDA label states: "Discontinue this product promptly if sensitization or irritation occurs" 1
  2. Contact your physician for alternative treatment

    • Request non-neomycin containing ear drops
    • Fluoroquinolone preparations (like ciprofloxacin) are recommended alternatives 4
  3. Treat the skin reaction

    • Gently cleanse the affected area with mild soap and water
    • Apply a thin layer of hydrocortisone cream to reduce inflammation
    • Avoid harsh soaps or rubbing the area 4
  4. Prevent future reactions

    • After administering ear drops, wipe away any excess medication
    • Consider placing a cotton ball gently in the ear canal to prevent drainage
    • Avoid all neomycin-containing products in the future 1

Important Considerations

  • Once sensitized to neomycin, your child may react more quickly and severely with future exposures 2
  • Simultaneous allergies to neomycin, bacitracin, and polymyxin can occur 5
  • The reaction should resolve within days of discontinuing the offending agent
  • Document this reaction in your child's medical record to avoid future exposure

When to Seek Further Medical Care

  • If the rash spreads, worsens, or develops blisters
  • If your child develops fever or appears ill
  • If the ear infection symptoms worsen despite alternative treatment

This type of allergic reaction is well-documented and should resolve completely once the medication is discontinued and appropriate alternatives are used.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contact Allergy to Polymyxin B Among Patients Referred for Patch Testing.

Dermatitis : contact, atopic, occupational, drug, 2016

Guideline

Acute Otitis Externa Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Simultaneous contact allergy to neomycin, bacitracin, and polymyxin.

Journal of the American Academy of Dermatology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.